Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Simple-Prep Controlled Embolic (GPX Trial)

NCT06453642 is registered in ClinicalTrials.gov with Fluidx Medical Technology, Inc. as lead sponsor.

NCT NCT06453642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06453642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Simple-Prep Controlled Embolic (GPX Trial)
Lead sponsor
Fluidx Medical Technology, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 18, 2024
Completion date
September 30, 2026
Enrollment
114 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

bone tumor, embolization, portal vein embolization, renal angiomyolipoma, renal cell carcinoma, vascular tumor